Candel Therapeutics Inc (CADL) Implied Volatility Current

Tracking CADL implied volatility helps you identify when options premiums on Candel Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Candel Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when CADL IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Candel Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CADL, tracking metrics like CADL IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CADL signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc.

and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CADL implied volatility sits today versus where it has been. Our scanner ranks Candel Therapeutics Inc implied volatility against its historical range, surfaces extremes in CADL IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Candel Therapeutics Inc IV is rich or cheap — measure it, then act on it.